Ersin Erek, Agop Çıtak, Halil İbrahim Demir, Güntülü Şık, Selim Aydın, Agageldi Annayev, Asuman Demirbuğa, Elif Deliceo

Extracorporeal membrane oxygenation for the support of pediatric patients with acute fulminant myocarditis

Acute fulminant myocarditis, is a severe, rapidly progressive disease. Theclinical outcomes of children with severe acute myocarditis who are resistto medical treatment is not well known. We studied the clinical courses ofpatients with acute fulminant myocarditis supported by extracorporealmembrane oxygenation (ECMO). We performed a retrospective chart reviewof six children with acute fulminant myocarditis who were treated with ECMO.Demographic information, clinical and vital signs, as well as laboratory resultswere investigated. The median age of 63 months (13-140 months), the meanECMO duration was 164 hours (79-402 hours), and median intensive careunit stay was 24 days. The most common symptoms were chest pain (66%)and fever (66%). Severe arrhythmia were seen in two patients. One patientreceived extracorporeal cardiopulmonary resuscitation. In two patients, rightfemoral arteries and right femoral veins were used, in others, right commoncarotid artery and right internal jugular veins were used. Five patients (83.3%) survived to discharge. ECMO can be used effectively in pediatric patientswith acute fulminant myocarditis to support the circulation while awaitingmyocardial recovery. Timely use of ECMO can improve the survival rate andmay be associated with better outcomes.

PDF

___

1. Kearney MT, Cotton JM, Richardson PR, Shah AM. Viral myocarditis and dilated cardiomyopathy: Mechanisms, manifestations and management. Postgrad Med J 2001; 77: 4-10.
2. Cooper LT Jr. Myocarditis. N Engl J Med 2009; 360: 1526-1538.
3. Durani Y, Egan M, Baffa J, Selbst SM, Nager AL. Pediatric myocarditis: presenting clinical characteristics. Am J Emerg Med 2009; 27: 942-947.
4. Brown KL, Ichord R, Marino BS, Thiagarajan RR. Outcomes following extracorporeal membrane oxygenation in children with cardiac disease. Pediatr Crit Care Med 2013; 14: 73-83.
5. Wilmo I, Morales DL, Price JF, et al. Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis. J Card Fail 2011; 17: 487-494.
6. Teele SA, Allan CK, Laussen PC, Newburger JW, Gauvreau K, Thiagarajan RR. Management and outcomes in pediatric patients presenting with acute fulminant myocarditis. J Pediatr 2011; 158: 638-643. e1.
7. Rajagopal SK, Almond CS, Laussen PC, Rycus PT, Wypij D, Thiagarajan RR. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry. Crit Care Med 2010; 38: 382-387.
8. Shu-Ling C, Bautista D, Kit CC, Su-Yin AA. Diagnostic evaluation of pediatric myocarditis in the emergency department: a 10-year case series in the Asian population. Pediatr Emerg Care 2013; 29: 346- 351.
9. Freedman SB, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J. Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics 2007; 120: 1278-1285.
10. Vashist S, Singh GK. Acute myocarditis in children: current concepts and management. Curr Treat Options Cardiovasc Med 2009; 11: 383-391.
11. Kodama M, Oda H, Okabe M, Aizawa Y, Izumi T. Early and long-term mortality of the clinical subtypes of myocarditis. Jpn Circ J 2001; 65: 961-964.
12. Lee EY, Lee HL, Kim HT, Lee HD, Park JA. Clinical features and short-term outcomes of pediatric acute fulminant myocarditis in a single center. Korean J Pediatr 2014; 57: 489-495.
13. Wu HP, Lin MJ, Yang WC, Wu KH, Chen CY. Predictors of extracorporeal membrane oxygenation support for children with acute myocarditis. Biomed Res Int 2017; 2017: 2510695.
14. Jung SY, Shin HJ, Jung JW, et al. Extracorporeal life support can be a first-line treatment in children with acute fulminant myocarditis. Interact Cardiovasc Thorac Surg 2016; 23: 247-252.
15. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001; 122: 440-448.
16. Kato S, Morimoto S, Hiramitsu S, et al. Risk factors for patients developing a fulminant course with acute myocarditis. Circ J 2004; 68: 734-739.
17. Al-Biltagi M, Isaa M, Hagar HA, Abdel-Hafez M, Aziz NA. Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis. myocarditis. Acta Paediatr 2010; 99: 1510-1516.